China SXT Pharmaceuticals Financial Overview
China SXT Pharmaceuticals's market cap is currently $182.16M. The company's EPS TTM is $2.725; its P/E ratio is -0.71; China SXT Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.